These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 22398969)
1. Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers. Sistonen J; Madadi P; Ross CJ; Yazdanpanah M; Lee JW; Landsmeer ML; Nauta M; Carleton BC; Koren G; Hayden MR Clin Pharmacol Ther; 2012 Apr; 91(4):692-9. PubMed ID: 22398969 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study. Madadi P; Ross CJ; Hayden MR; Carleton BC; Gaedigk A; Leeder JS; Koren G Clin Pharmacol Ther; 2009 Jan; 85(1):31-5. PubMed ID: 18719619 [TBL] [Abstract][Full Text] [Related]
3. A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk. Kelly LE; Chaudhry SA; Rieder MJ; 't Jong G; Moretti ME; Lausman A; Ross C; Berger H; Carleton B; Hayden MR; Madadi P; Koren G PLoS One; 2013; 8(7):e70073. PubMed ID: 23922910 [TBL] [Abstract][Full Text] [Related]
4. Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia. Lam J; Kelly L; Ciszkowski C; Landsmeer ML; Nauta M; Carleton BC; Hayden MR; Madadi P; Koren G J Pediatr; 2012 Jan; 160(1):33-7.e2. PubMed ID: 21880331 [TBL] [Abstract][Full Text] [Related]
5. Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine. Madadi P; Koren G; Cairns J; Chitayat D; Gaedigk A; Leeder JS; Teitelbaum R; Karaskov T; Aleksa K Can Fam Physician; 2007 Jan; 53(1):33-5. PubMed ID: 17872605 [TBL] [Abstract][Full Text] [Related]
6. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy. Crews KR; Monte AA; Huddart R; Caudle KE; Kharasch ED; Gaedigk A; Dunnenberger HM; Leeder JS; Callaghan JT; Samer CF; Klein TE; Haidar CE; Van Driest SL; Ruano G; Sangkuhl K; Cavallari LH; Müller DJ; Prows CA; Nagy M; Somogyi AA; Skaar TC Clin Pharmacol Ther; 2021 Oct; 110(4):888-896. PubMed ID: 33387367 [TBL] [Abstract][Full Text] [Related]
7. Establishing causality of CNS depression in breastfed infants following maternal codeine use. Madadi P; Shirazi F; Walter FG; Koren G Paediatr Drugs; 2008; 10(6):399-404. PubMed ID: 18998750 [TBL] [Abstract][Full Text] [Related]
8. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action. Lötsch J; Skarke C; Wieting J; Oertel BG; Schmidt H; Brockmöller J; Geisslinger G Clin Pharmacol Ther; 2006 Jan; 79(1):72-89. PubMed ID: 16413243 [TBL] [Abstract][Full Text] [Related]
9. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study. VanderVaart S; Berger H; Sistonen J; Madadi P; Matok I; Gijsen VM; de Wildt SN; Taddio A; Ross CJ; Carleton BC; Hayden MR; Koren G Ther Drug Monit; 2011 Aug; 33(4):425-32. PubMed ID: 21743374 [TBL] [Abstract][Full Text] [Related]
10. Risk to the breast-fed neonate from codeine treatment to the mother: a quantitative mechanistic modeling study. Willmann S; Edginton AN; Coboeken K; Ahr G; Lippert J Clin Pharmacol Ther; 2009 Dec; 86(6):634-43. PubMed ID: 19710640 [TBL] [Abstract][Full Text] [Related]
11. Putative association of ABCB1 2677G>T/A with oxycodone-induced central nervous system depression in breastfeeding mothers. Lam J; Kelly L; Matok I; Ross CJ; Carleton BC; Hayden MR; Madadi P; Koren G Ther Drug Monit; 2013 Aug; 35(4):466-72. PubMed ID: 23783165 [TBL] [Abstract][Full Text] [Related]
12. Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers. McLaughlin P; Mactier H; Gillis C; Hickish T; Parker A; Liang WJ; Osselton MD J Pediatr; 2017 Nov; 190():180-184.e1. PubMed ID: 28867064 [TBL] [Abstract][Full Text] [Related]
13. Ethical considerations in CYP2D6 genotype testing for codeine-prescribed breastfeeding mothers. Kurtz M; Black Golde P; Berlinger N Clin Pharmacol Ther; 2010 Dec; 88(6):760-2. PubMed ID: 21081947 [TBL] [Abstract][Full Text] [Related]
14. Predicted activity of UGT2B7, ABCB1, OPRM1, and COMT using full-gene haplotypes and their association with the CYP2D6-inferred metabolizer phenotype. Wendt FR; Sajantila A; Budowle B Forensic Sci Int Genet; 2018 Mar; 33():48-58. PubMed ID: 29190510 [TBL] [Abstract][Full Text] [Related]
15. Effect of genetic factors on opioid action. Kosarac B; Fox AA; Collard CD Curr Opin Anaesthesiol; 2009 Aug; 22(4):476-82. PubMed ID: 19502975 [TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics in palliative care. Kleine-Brueggeney M; Musshoff F; Stuber F; Stamer UM Forensic Sci Int; 2010 Dec; 203(1-3):63-70. PubMed ID: 20709477 [TBL] [Abstract][Full Text] [Related]
17. Current evidence for a genetic modulation of the response to analgesics. Lötsch J; Geisslinger G Pain; 2006 Mar; 121(1-2):1-5. PubMed ID: 16472919 [No Abstract] [Full Text] [Related]
18. Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits. Madadi P; Joly Y; Avard D; Chitayat DC; Smith MA; Ross CJ; Carleton BC; Hayden MR; Koren G Clin Pharmacol Ther; 2010 Dec; 88(6):792-5. PubMed ID: 20739920 [TBL] [Abstract][Full Text] [Related]
19. The pharmacogenetics of codeine pain relief in the postpartum period. Baber M; Chaudhry S; Kelly L; Ross C; Carleton B; Berger H; Koren G Pharmacogenomics J; 2015 Oct; 15(5):430-5. PubMed ID: 25752520 [TBL] [Abstract][Full Text] [Related]
20. Genetic transmission of cytochrome P450 2D6 (CYP2D6) ultrarapid metabolism: implications for breastfeeding women taking codeine. Madadi P; Ciszkowski C; Gaedigk A; Leeder JS; Teitelbaum R; Chitayat D; Koren G Curr Drug Saf; 2011 Feb; 6(1):36-9. PubMed ID: 21241245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]